Coagulase-Negative Staphylococci Infections in Neonatal Care

Summary

Coagulase-negative staphylococci (CoNS) have emerged as the principal pathogens responsible for late-onset sepsis in neonatal intensive care units worldwide. These bacteria, once regarded as harmless skin commensals, exploit indwelling devices such as central venous catheters and endotracheal tubes to adhere, form biofilms and evade host defences. Preterm infants, with their immature immune systems and frequent requirement for invasive support, are particularly susceptible. In recent years there has been growing recognition of specific multidrug-resistant lineages—most notably the NRCS-A clone of Staphylococcus capitis—which persist in the neonatal environment and demonstrate reduced susceptibility to glycopeptides and antiseptics. Outbreaks often involve complex transmission pathways linking incubator surfaces, caregiver hands and the hospital environment. Management strategies now emphasise targeted antimicrobial stewardship, rigorous device management and novel approaches to disrupt biofilm formation, underscoring the need for integrated infection-control programmes.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Coagulase-Negative Staphylococci Infections in Neonatal Care publication trend

The graph below shows the total number of articles in coagulase-negative staphylococci infections in neonatal care across all publications each year (not limited to Nature Index journals).

Technical terms

Coagulase-negative staphylococci (CoNS): group of staphylococcal species lacking the coagulase enzyme, commonly implicated in device-related infections in neonates.

Late-onset sepsis (LOS): bloodstream infection occurring in neonates after 72 hours of life, typically associated with hospital-acquired pathogens.

Biofilm: structured microbial community embedded in a self-produced extracellular matrix, conferring protection against host immunity and antimicrobials.

NRCS-A clone: a predominant multidrug-resistant lineage of Staphylococcus capitis adapted for persistence and transmission in neonatal intensive care environments.

Whole-genome sequencing (WGS): comprehensive analysis of an organism’s complete DNA sequence, used to trace transmission routes and genetic adaptations of pathogens.

References

  1. Whole-genome sequencing reveals widespread presence of Staphylococcus capitis NRCS-A clone in neonatal units across the United Kingdom. Journal of Infection (2023).
  2. Disinfection of incubators in neonatal intensive care units: impact of steam pulverization on bacterial colonization. Antimicrobial Resistance & Infection Control (2023).
  3. Characterisation of neonatal Staphylococcus capitis NRCS-A isolates compared with non NRCS-A Staphylococcus capitis from neonates and adults. Microbial Genomics (2023).
  4. Sources and reservoirs of Staphylococcus capitis NRCS-A inside a NICU. Antimicrobial Resistance & Infection Control (2019).

About these summaries

This Nature Research Intelligence Topic summary is created with the cited references and a large language model. We take care to ground generated text with facts, and have systems in place to gain human feedback on the overall quality of the process in line with our AI principles. We strive to create accurate and useful summaries for people unfamiliar with the research topic and that supports this goal. These pages are a beta release and will be updated as we learn how best to help people gain value from a research topic summary.

Nature Index 2026 Regenerative medicine

Regenerative medicine has the potential to transform the treatment of chronic and life-threatening diseases. But major challenges remain, such as overcoming immune rejection and ensuring that new therapies are developed using more inclusive data sets. In this supplement, we explore the discoveries that are driving the field, the barriers that could limit its progress, and the teams and institutions that are making their mark.

Nature Index 2026 Regenerative medicine
Access for free
Nature Strategy Reports
Turn complex research questions into confident strategic decisions 

When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.

  • Benchmark your performance against global peers using robust, methodologically sound analysis.

  • Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.

  • Gain tailored, decision-ready recommendations aligned to your strategic priorities.

Talk to us to learn more about our data dashboards and bespoke strategy reports.

Nature Masterclasses
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.

Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:

  • Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.

  • Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.

  • Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.

Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.